nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—AGTR1—dilated cardiomyopathy	0.296	0.634	CbGaD
Losartan—ACE—Lisinopril—dilated cardiomyopathy	0.23	0.641	CbGbCtD
Losartan—ACE—dilated cardiomyopathy	0.171	0.366	CbGaD
Losartan—SLC22A6—Furosemide—dilated cardiomyopathy	0.0306	0.0853	CbGbCtD
Losartan—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0294	0.0821	CbGbCtD
Losartan—ALB—Furosemide—dilated cardiomyopathy	0.026	0.0726	CbGbCtD
Losartan—ABCB1—Lisinopril—dilated cardiomyopathy	0.0226	0.0631	CbGbCtD
Losartan—ABCB1—Spironolactone—dilated cardiomyopathy	0.0199	0.0556	CbGbCtD
Losartan—Coxalgia—Lisinopril—dilated cardiomyopathy	0.00578	0.0543	CcSEcCtD
Losartan—Knee pain—Lisinopril—dilated cardiomyopathy	0.00511	0.048	CcSEcCtD
Losartan—CYP2C9—cardial valve—dilated cardiomyopathy	0.00511	0.273	CbGeAlD
Losartan—Angiitis necrotising—Furosemide—dilated cardiomyopathy	0.00352	0.033	CcSEcCtD
Losartan—Xanthopsia—Furosemide—dilated cardiomyopathy	0.00352	0.033	CcSEcCtD
Losartan—ACE—pulmonary artery—dilated cardiomyopathy	0.00317	0.17	CbGeAlD
Losartan—Dry cough—Lisinopril—dilated cardiomyopathy	0.00312	0.0292	CcSEcCtD
Losartan—ACE—sympathetic nervous system—dilated cardiomyopathy	0.00308	0.165	CbGeAlD
Losartan—Vasculitis necrotising—Furosemide—dilated cardiomyopathy	0.00307	0.0288	CcSEcCtD
Losartan—Pain in arm—Lisinopril—dilated cardiomyopathy	0.00294	0.0276	CcSEcCtD
Losartan—Shoulder pain—Lisinopril—dilated cardiomyopathy	0.00179	0.0168	CcSEcCtD
Losartan—Gastric irritation—Furosemide—dilated cardiomyopathy	0.00166	0.0155	CcSEcCtD
Losartan—SLC2A9—heart—dilated cardiomyopathy	0.00153	0.0819	CbGeAlD
Losartan—Tasosartan—AGTR2—dilated cardiomyopathy	0.00141	0.216	CrCbGaD
Losartan—Epigastric discomfort—Furosemide—dilated cardiomyopathy	0.00122	0.0115	CcSEcCtD
Losartan—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00121	0.0114	CcSEcCtD
Losartan—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.00116	0.0109	CcSEcCtD
Losartan—Eprosartan—AGTR1—dilated cardiomyopathy	0.00106	0.163	CrCbGaD
Losartan—Leg pain—Lisinopril—dilated cardiomyopathy	0.00104	0.0098	CcSEcCtD
Losartan—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.000951	0.00893	CcSEcCtD
Losartan—AGTR1—cardiac ventricle—dilated cardiomyopathy	0.000892	0.0478	CbGeAlD
Losartan—Azilsartan medoxomil—AGTR1—dilated cardiomyopathy	0.000866	0.133	CrCbGaD
Losartan—AGTR1—myocardium—dilated cardiomyopathy	0.000839	0.045	CbGeAlD
Losartan—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.000839	0.00787	CcSEcCtD
Losartan—Ataxia—Spironolactone—dilated cardiomyopathy	0.000806	0.00756	CcSEcCtD
Losartan—Forasartan—AGTR1—dilated cardiomyopathy	0.000805	0.124	CrCbGaD
Losartan—Glycosuria—Furosemide—dilated cardiomyopathy	0.000793	0.00744	CcSEcCtD
Losartan—Serum creatinine increased—Lisinopril—dilated cardiomyopathy	0.000783	0.00735	CcSEcCtD
Losartan—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.000772	0.00724	CcSEcCtD
Losartan—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.000772	0.00724	CcSEcCtD
Losartan—Gastritis—Spironolactone—dilated cardiomyopathy	0.000758	0.00712	CcSEcCtD
Losartan—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.000733	0.00688	CcSEcCtD
Losartan—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.000731	0.00686	CcSEcCtD
Losartan—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.000692	0.0065	CcSEcCtD
Losartan—Gout—Furosemide—dilated cardiomyopathy	0.000688	0.00646	CcSEcCtD
Losartan—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.000682	0.0064	CcSEcCtD
Losartan—ACE—cardiac ventricle—dilated cardiomyopathy	0.000659	0.0353	CbGeAlD
Losartan—Vasculitis—Furosemide—dilated cardiomyopathy	0.000658	0.00618	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.000655	0.00615	CcSEcCtD
Losartan—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.000654	0.00614	CcSEcCtD
Losartan—Renal failure—Spironolactone—dilated cardiomyopathy	0.000649	0.00609	CcSEcCtD
Losartan—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.000629	0.00591	CcSEcCtD
Losartan—ACE—myocardium—dilated cardiomyopathy	0.00062	0.0332	CbGeAlD
Losartan—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000616	0.00578	CcSEcCtD
Losartan—Memory impairment—Lisinopril—dilated cardiomyopathy	0.000614	0.00576	CcSEcCtD
Losartan—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.000603	0.00566	CcSEcCtD
Losartan—AGTR1—heart—dilated cardiomyopathy	0.000586	0.0314	CbGeAlD
Losartan—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000561	0.00526	CcSEcCtD
Losartan—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.000548	0.00515	CcSEcCtD
Losartan—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.000536	0.00503	CcSEcCtD
Losartan—Photosensitivity—Furosemide—dilated cardiomyopathy	0.000531	0.00498	CcSEcCtD
Losartan—Swelling—Furosemide—dilated cardiomyopathy	0.000529	0.00496	CcSEcCtD
Losartan—Alopecia—Spironolactone—dilated cardiomyopathy	0.000524	0.00492	CcSEcCtD
Losartan—Vascular purpura—Furosemide—dilated cardiomyopathy	0.000521	0.00489	CcSEcCtD
Losartan—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.000516	0.00485	CcSEcCtD
Losartan—Gout—Lisinopril—dilated cardiomyopathy	0.000516	0.00484	CcSEcCtD
Losartan—AGTR1—cardiac atrium—dilated cardiomyopathy	0.000501	0.0268	CbGeAlD
Losartan—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000496	0.00466	CcSEcCtD
Losartan—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.000494	0.00464	CcSEcCtD
Losartan—Vasculitis—Lisinopril—dilated cardiomyopathy	0.000494	0.00463	CcSEcCtD
Losartan—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.000488	0.00458	CcSEcCtD
Losartan—Tasosartan—AGTR1—dilated cardiomyopathy	0.000488	0.075	CrCbGaD
Losartan—Purpura—Furosemide—dilated cardiomyopathy	0.000484	0.00454	CcSEcCtD
Losartan—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.000482	0.00452	CcSEcCtD
Losartan—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000479	0.00449	CcSEcCtD
Losartan—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.000473	0.00444	CcSEcCtD
Losartan—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000468	0.00439	CcSEcCtD
Losartan—Malaise—Spironolactone—dilated cardiomyopathy	0.000465	0.00437	CcSEcCtD
Losartan—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000462	0.00434	CcSEcCtD
Losartan—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.000455	0.00427	CcSEcCtD
Losartan—ALB—heart—dilated cardiomyopathy	0.000452	0.0242	CbGeAlD
Losartan—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000437	0.0041	CcSEcCtD
Losartan—Discomfort—Spironolactone—dilated cardiomyopathy	0.000434	0.00407	CcSEcCtD
Losartan—ACE—heart—dilated cardiomyopathy	0.000433	0.0232	CbGeAlD
Losartan—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000429	0.00403	CcSEcCtD
Losartan—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000426	0.004	CcSEcCtD
Losartan—Confusional state—Spironolactone—dilated cardiomyopathy	0.000425	0.00399	CcSEcCtD
Losartan—Valsartan—AGTR1—dilated cardiomyopathy	0.000423	0.065	CrCbGaD
Losartan—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000421	0.00395	CcSEcCtD
Losartan—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00042	0.00394	CcSEcCtD
Losartan—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00042	0.00394	CcSEcCtD
Losartan—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000412	0.00387	CcSEcCtD
Losartan—Olmesartan—AGTR1—dilated cardiomyopathy	0.000412	0.0634	CrCbGaD
Losartan—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000411	0.00386	CcSEcCtD
Losartan—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.000404	0.00379	CcSEcCtD
Losartan—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000402	0.00377	CcSEcCtD
Losartan—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000399	0.00374	CcSEcCtD
Losartan—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.000398	0.00374	CcSEcCtD
Losartan—Telmisartan—AGTR1—dilated cardiomyopathy	0.000397	0.0611	CrCbGaD
Losartan—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000395	0.00371	CcSEcCtD
Losartan—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000388	0.00364	CcSEcCtD
Losartan—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.000384	0.0036	CcSEcCtD
Losartan—Injury—Lisinopril—dilated cardiomyopathy	0.000381	0.00357	CcSEcCtD
Losartan—Libido decreased—Lisinopril—dilated cardiomyopathy	0.000377	0.00354	CcSEcCtD
Losartan—Somnolence—Spironolactone—dilated cardiomyopathy	0.000374	0.00351	CcSEcCtD
Losartan—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000372	0.00349	CcSEcCtD
Losartan—ACE—cardiac atrium—dilated cardiomyopathy	0.00037	0.0198	CbGeAlD
Losartan—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.000369	0.00346	CcSEcCtD
Losartan—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000368	0.00345	CcSEcCtD
Losartan—Renal impairment—Lisinopril—dilated cardiomyopathy	0.000368	0.00345	CcSEcCtD
Losartan—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000364	0.00341	CcSEcCtD
Losartan—Arthritis—Lisinopril—dilated cardiomyopathy	0.00036	0.00338	CcSEcCtD
Losartan—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000358	0.00336	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000356	0.00334	CcSEcCtD
Losartan—Renal failure—Furosemide—dilated cardiomyopathy	0.000353	0.00332	CcSEcCtD
Losartan—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000351	0.0033	CcSEcCtD
Losartan—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00035	0.00328	CcSEcCtD
Losartan—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000347	0.00326	CcSEcCtD
Losartan—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.000347	0.00326	CcSEcCtD
Losartan—Sweating—Furosemide—dilated cardiomyopathy	0.000344	0.00323	CcSEcCtD
Losartan—Face oedema—Lisinopril—dilated cardiomyopathy	0.000338	0.00317	CcSEcCtD
Losartan—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000335	0.00315	CcSEcCtD
Losartan—Urticaria—Spironolactone—dilated cardiomyopathy	0.000335	0.00314	CcSEcCtD
Losartan—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000333	0.00313	CcSEcCtD
Losartan—Ataxia—Lisinopril—dilated cardiomyopathy	0.000329	0.00309	CcSEcCtD
Losartan—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000328	0.00308	CcSEcCtD
Losartan—Candesartan—AGTR1—dilated cardiomyopathy	0.00032	0.0493	CrCbGaD
Losartan—Irbesartan—AGTR1—dilated cardiomyopathy	0.00032	0.0493	CrCbGaD
Losartan—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00032	0.003	CcSEcCtD
Losartan—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000316	0.00297	CcSEcCtD
Losartan—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000315	0.00296	CcSEcCtD
Losartan—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000315	0.00296	CcSEcCtD
Losartan—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00031	0.00291	CcSEcCtD
Losartan—Gastritis—Lisinopril—dilated cardiomyopathy	0.00031	0.00291	CcSEcCtD
Losartan—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000305	0.00286	CcSEcCtD
Losartan—Influenza—Lisinopril—dilated cardiomyopathy	0.000302	0.00284	CcSEcCtD
Losartan—Tinnitus—Furosemide—dilated cardiomyopathy	0.000301	0.00282	CcSEcCtD
Losartan—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000299	0.00281	CcSEcCtD
Losartan—Pruritus—Spironolactone—dilated cardiomyopathy	0.000298	0.0028	CcSEcCtD
Losartan—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000296	0.00278	CcSEcCtD
Losartan—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000295	0.00276	CcSEcCtD
Losartan—Angiopathy—Furosemide—dilated cardiomyopathy	0.000293	0.00275	CcSEcCtD
Losartan—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000291	0.00273	CcSEcCtD
Losartan—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000288	0.0027	CcSEcCtD
Losartan—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000288	0.0027	CcSEcCtD
Losartan—CYP2C9—heart—dilated cardiomyopathy	0.000282	0.0151	CbGeAlD
Losartan—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000281	0.00264	CcSEcCtD
Losartan—Erythema—Furosemide—dilated cardiomyopathy	0.000281	0.00264	CcSEcCtD
Losartan—Dizziness—Spironolactone—dilated cardiomyopathy	0.000279	0.00261	CcSEcCtD
Losartan—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000278	0.00261	CcSEcCtD
Losartan—Flatulence—Furosemide—dilated cardiomyopathy	0.000277	0.0026	CcSEcCtD
Losartan—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000276	0.00259	CcSEcCtD
Losartan—Weight increased—Lisinopril—dilated cardiomyopathy	0.000275	0.00258	CcSEcCtD
Losartan—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000275	0.00258	CcSEcCtD
Losartan—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000273	0.00256	CcSEcCtD
Losartan—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000271	0.00255	CcSEcCtD
Losartan—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00027	0.00253	CcSEcCtD
Losartan—Vomiting—Spironolactone—dilated cardiomyopathy	0.000268	0.00251	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000267	0.00251	CcSEcCtD
Losartan—Rash—Spironolactone—dilated cardiomyopathy	0.000266	0.00249	CcSEcCtD
Losartan—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000265	0.00249	CcSEcCtD
Losartan—Renal failure—Lisinopril—dilated cardiomyopathy	0.000265	0.00249	CcSEcCtD
Losartan—Vision blurred—Furosemide—dilated cardiomyopathy	0.000265	0.00248	CcSEcCtD
Losartan—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000264	0.00248	CcSEcCtD
Losartan—Headache—Spironolactone—dilated cardiomyopathy	0.000264	0.00248	CcSEcCtD
Losartan—Jaundice—Lisinopril—dilated cardiomyopathy	0.000263	0.00247	CcSEcCtD
Losartan—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000262	0.00246	CcSEcCtD
Losartan—Anaemia—Furosemide—dilated cardiomyopathy	0.00026	0.00244	CcSEcCtD
Losartan—Sweating—Lisinopril—dilated cardiomyopathy	0.000258	0.00243	CcSEcCtD
Losartan—Agitation—Furosemide—dilated cardiomyopathy	0.000258	0.00242	CcSEcCtD
Losartan—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000254	0.00239	CcSEcCtD
Losartan—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000253	0.00237	CcSEcCtD
Losartan—Vertigo—Furosemide—dilated cardiomyopathy	0.000252	0.00237	CcSEcCtD
Losartan—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000252	0.00236	CcSEcCtD
Losartan—Leukopenia—Furosemide—dilated cardiomyopathy	0.000251	0.00236	CcSEcCtD
Losartan—Nausea—Spironolactone—dilated cardiomyopathy	0.00025	0.00235	CcSEcCtD
Losartan—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000243	0.00228	CcSEcCtD
Losartan—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000242	0.00227	CcSEcCtD
Losartan—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00024	0.00225	CcSEcCtD
Losartan—Dry mouth—Furosemide—dilated cardiomyopathy	0.000234	0.00219	CcSEcCtD
Losartan—Confusional state—Furosemide—dilated cardiomyopathy	0.000231	0.00217	CcSEcCtD
Losartan—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000229	0.00215	CcSEcCtD
Losartan—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000229	0.00215	CcSEcCtD
Losartan—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000226	0.00212	CcSEcCtD
Losartan—Shock—Furosemide—dilated cardiomyopathy	0.000225	0.00212	CcSEcCtD
Losartan—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000225	0.00211	CcSEcCtD
Losartan—Flushing—Lisinopril—dilated cardiomyopathy	0.000225	0.00211	CcSEcCtD
Losartan—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000224	0.00211	CcSEcCtD
Losartan—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000222	0.00208	CcSEcCtD
Losartan—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00022	0.00206	CcSEcCtD
Losartan—Anorexia—Furosemide—dilated cardiomyopathy	0.000218	0.00205	CcSEcCtD
Losartan—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000216	0.00203	CcSEcCtD
Losartan—Hypotension—Furosemide—dilated cardiomyopathy	0.000214	0.00201	CcSEcCtD
Losartan—Alopecia—Lisinopril—dilated cardiomyopathy	0.000214	0.00201	CcSEcCtD
Losartan—Erythema—Lisinopril—dilated cardiomyopathy	0.000211	0.00198	CcSEcCtD
Losartan—Flatulence—Lisinopril—dilated cardiomyopathy	0.000208	0.00195	CcSEcCtD
Losartan—Tension—Lisinopril—dilated cardiomyopathy	0.000207	0.00194	CcSEcCtD
Losartan—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000206	0.00194	CcSEcCtD
Losartan—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000206	0.00193	CcSEcCtD
Losartan—Nervousness—Lisinopril—dilated cardiomyopathy	0.000205	0.00192	CcSEcCtD
Losartan—Back pain—Lisinopril—dilated cardiomyopathy	0.000204	0.00191	CcSEcCtD
Losartan—Somnolence—Furosemide—dilated cardiomyopathy	0.000204	0.00191	CcSEcCtD
Losartan—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000203	0.0019	CcSEcCtD
Losartan—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000199	0.00187	CcSEcCtD
Losartan—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000199	0.00186	CcSEcCtD
Losartan—Fatigue—Furosemide—dilated cardiomyopathy	0.000198	0.00185	CcSEcCtD
Losartan—Tremor—Lisinopril—dilated cardiomyopathy	0.000197	0.00185	CcSEcCtD
Losartan—Pain—Furosemide—dilated cardiomyopathy	0.000196	0.00184	CcSEcCtD
Losartan—Constipation—Furosemide—dilated cardiomyopathy	0.000196	0.00184	CcSEcCtD
Losartan—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000195	0.00183	CcSEcCtD
Losartan—Anaemia—Lisinopril—dilated cardiomyopathy	0.000195	0.00183	CcSEcCtD
Losartan—Angioedema—Lisinopril—dilated cardiomyopathy	0.000193	0.00181	CcSEcCtD
Losartan—Malaise—Lisinopril—dilated cardiomyopathy	0.00019	0.00178	CcSEcCtD
Losartan—Vertigo—Lisinopril—dilated cardiomyopathy	0.000189	0.00178	CcSEcCtD
Losartan—Syncope—Lisinopril—dilated cardiomyopathy	0.000189	0.00177	CcSEcCtD
Losartan—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000189	0.00177	CcSEcCtD
Losartan—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000189	0.00177	CcSEcCtD
Losartan—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000187	0.00176	CcSEcCtD
Losartan—Palpitations—Lisinopril—dilated cardiomyopathy	0.000186	0.00175	CcSEcCtD
Losartan—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000185	0.00174	CcSEcCtD
Losartan—Cough—Lisinopril—dilated cardiomyopathy	0.000184	0.00173	CcSEcCtD
Losartan—Urticaria—Furosemide—dilated cardiomyopathy	0.000182	0.00171	CcSEcCtD
Losartan—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000181	0.0017	CcSEcCtD
Losartan—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000181	0.0017	CcSEcCtD
Losartan—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000179	0.00168	CcSEcCtD
Losartan—Myalgia—Lisinopril—dilated cardiomyopathy	0.000179	0.00168	CcSEcCtD
Losartan—Chest pain—Lisinopril—dilated cardiomyopathy	0.000179	0.00168	CcSEcCtD
Losartan—Anxiety—Lisinopril—dilated cardiomyopathy	0.000179	0.00168	CcSEcCtD
Losartan—Discomfort—Lisinopril—dilated cardiomyopathy	0.000177	0.00166	CcSEcCtD
Losartan—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000175	0.00165	CcSEcCtD
Losartan—Confusional state—Lisinopril—dilated cardiomyopathy	0.000173	0.00163	CcSEcCtD
Losartan—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000172	0.00161	CcSEcCtD
Losartan—Oedema—Lisinopril—dilated cardiomyopathy	0.000172	0.00161	CcSEcCtD
Losartan—Infection—Lisinopril—dilated cardiomyopathy	0.000171	0.0016	CcSEcCtD
Losartan—Shock—Lisinopril—dilated cardiomyopathy	0.000169	0.00159	CcSEcCtD
Losartan—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000169	0.00158	CcSEcCtD
Losartan—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000168	0.00158	CcSEcCtD
Losartan—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000168	0.00158	CcSEcCtD
Losartan—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000166	0.00156	CcSEcCtD
Losartan—Asthenia—Furosemide—dilated cardiomyopathy	0.000164	0.00154	CcSEcCtD
Losartan—Anorexia—Lisinopril—dilated cardiomyopathy	0.000164	0.00154	CcSEcCtD
Losartan—Pruritus—Furosemide—dilated cardiomyopathy	0.000162	0.00152	CcSEcCtD
Losartan—Hypotension—Lisinopril—dilated cardiomyopathy	0.000161	0.00151	CcSEcCtD
Losartan—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000157	0.00147	CcSEcCtD
Losartan—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000157	0.00147	CcSEcCtD
Losartan—Insomnia—Lisinopril—dilated cardiomyopathy	0.000156	0.00146	CcSEcCtD
Losartan—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000154	0.00145	CcSEcCtD
Losartan—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000153	0.00144	CcSEcCtD
Losartan—Somnolence—Lisinopril—dilated cardiomyopathy	0.000153	0.00143	CcSEcCtD
Losartan—ABCB1—heart—dilated cardiomyopathy	0.000152	0.00816	CbGeAlD
Losartan—Dizziness—Furosemide—dilated cardiomyopathy	0.000152	0.00142	CcSEcCtD
Losartan—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000151	0.00142	CcSEcCtD
Losartan—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000149	0.0014	CcSEcCtD
Losartan—Fatigue—Lisinopril—dilated cardiomyopathy	0.000148	0.00139	CcSEcCtD
Losartan—Constipation—Lisinopril—dilated cardiomyopathy	0.000147	0.00138	CcSEcCtD
Losartan—Pain—Lisinopril—dilated cardiomyopathy	0.000147	0.00138	CcSEcCtD
Losartan—Vomiting—Furosemide—dilated cardiomyopathy	0.000146	0.00137	CcSEcCtD
Losartan—Rash—Furosemide—dilated cardiomyopathy	0.000144	0.00136	CcSEcCtD
Losartan—Dermatitis—Furosemide—dilated cardiomyopathy	0.000144	0.00135	CcSEcCtD
Losartan—Headache—Furosemide—dilated cardiomyopathy	0.000144	0.00135	CcSEcCtD
Losartan—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000142	0.00133	CcSEcCtD
Losartan—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000141	0.00132	CcSEcCtD
Losartan—Urticaria—Lisinopril—dilated cardiomyopathy	0.000137	0.00128	CcSEcCtD
Losartan—Nausea—Furosemide—dilated cardiomyopathy	0.000136	0.00128	CcSEcCtD
Losartan—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000136	0.00128	CcSEcCtD
Losartan—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000136	0.00128	CcSEcCtD
Losartan—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000127	0.00119	CcSEcCtD
Losartan—Asthenia—Lisinopril—dilated cardiomyopathy	0.000123	0.00116	CcSEcCtD
Losartan—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	0.000122	0.00287	CbGpPWpGaD
Losartan—Pruritus—Lisinopril—dilated cardiomyopathy	0.000122	0.00114	CcSEcCtD
Losartan—AGTR1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.000121	0.00284	CbGpPWpGaD
Losartan—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000121	0.00284	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000119	0.00279	CbGpPWpGaD
Losartan—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000118	0.0011	CcSEcCtD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.000117	0.00274	CbGpPWpGaD
Losartan—Dizziness—Lisinopril—dilated cardiomyopathy	0.000114	0.00107	CcSEcCtD
Losartan—SLCO1B1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00011	0.00258	CbGpPWpGaD
Losartan—Vomiting—Lisinopril—dilated cardiomyopathy	0.000109	0.00103	CcSEcCtD
Losartan—Rash—Lisinopril—dilated cardiomyopathy	0.000108	0.00102	CcSEcCtD
Losartan—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000108	0.00102	CcSEcCtD
Losartan—Headache—Lisinopril—dilated cardiomyopathy	0.000108	0.00101	CcSEcCtD
Losartan—Nausea—Lisinopril—dilated cardiomyopathy	0.000102	0.000959	CcSEcCtD
Losartan—AGTR1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000102	0.00239	CbGpPWpGaD
Losartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	9.66e-05	0.00227	CbGpPWpGaD
Losartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	9.48e-05	0.00223	CbGpPWpGaD
Losartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—dilated cardiomyopathy	9.3e-05	0.00218	CbGpPWpGaD
Losartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	9.2e-05	0.00216	CbGpPWpGaD
Losartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	9.18e-05	0.00216	CbGpPWpGaD
Losartan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	8.94e-05	0.0021	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	8.74e-05	0.00205	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	8.74e-05	0.00205	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.56e-05	0.00201	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	8.49e-05	0.00199	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	8.32e-05	0.00195	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	8.32e-05	0.00195	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	8.12e-05	0.00191	CbGpPWpGaD
Losartan—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	8.08e-05	0.0019	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	7.98e-05	0.00187	CbGpPWpGaD
Losartan—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	7.88e-05	0.00185	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	7.87e-05	0.00185	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.74e-05	0.00182	CbGpPWpGaD
Losartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	7.44e-05	0.00175	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	7.36e-05	0.00173	CbGpPWpGaD
Losartan—AGTR1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	7.14e-05	0.00168	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	7.05e-05	0.00166	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	7.05e-05	0.00166	CbGpPWpGaD
Losartan—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	7.03e-05	0.00165	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—LMNA—dilated cardiomyopathy	6.94e-05	0.00163	CbGpPWpGaD
Losartan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	6.68e-05	0.00157	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	6.65e-05	0.00156	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	6.65e-05	0.00156	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	6.58e-05	0.00154	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—TNF—dilated cardiomyopathy	6.45e-05	0.00151	CbGpPWpGaD
Losartan—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	6.41e-05	0.00151	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	6.39e-05	0.0015	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	6.38e-05	0.0015	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	6.37e-05	0.0015	CbGpPWpGaD
Losartan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	6.36e-05	0.00149	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	6.32e-05	0.00148	CbGpPWpGaD
Losartan—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	6.29e-05	0.00148	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	6.27e-05	0.00147	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	6.19e-05	0.00145	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	6.15e-05	0.00144	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	6.15e-05	0.00144	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	5.99e-05	0.00141	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—ANKRD1—dilated cardiomyopathy	5.97e-05	0.0014	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	5.93e-05	0.00139	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.75e-05	0.00135	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.71e-05	0.00134	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	5.71e-05	0.00134	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—ANKRD1—dilated cardiomyopathy	5.62e-05	0.00132	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—TAZ—dilated cardiomyopathy	5.61e-05	0.00132	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—GPX1—dilated cardiomyopathy	5.61e-05	0.00132	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.59e-05	0.00131	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.59e-05	0.00131	CbGpPWpGaD
Losartan—SLC2A9—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.52e-05	0.0013	CbGpPWpGaD
Losartan—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	5.48e-05	0.00129	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—CD36—dilated cardiomyopathy	5.46e-05	0.00128	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	5.43e-05	0.00127	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—TAZ—dilated cardiomyopathy	5.29e-05	0.00124	CbGpPWpGaD
Losartan—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	5.24e-05	0.00123	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	5.23e-05	0.00123	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.2e-05	0.00122	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—SDHA—dilated cardiomyopathy	5.07e-05	0.00119	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—ANKRD1—dilated cardiomyopathy	5.07e-05	0.00119	CbGpPWpGaD
Losartan—SLC22A12—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.05e-05	0.00119	CbGpPWpGaD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	4.99e-05	0.00117	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	4.98e-05	0.00117	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	4.97e-05	0.00117	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—AGT—dilated cardiomyopathy	4.91e-05	0.00115	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.88e-05	0.00114	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	4.85e-05	0.00114	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.85e-05	0.00114	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—SDHA—dilated cardiomyopathy	4.78e-05	0.00112	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—TAZ—dilated cardiomyopathy	4.77e-05	0.00112	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	4.73e-05	0.00111	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	4.62e-05	0.00109	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.58e-05	0.00108	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.56e-05	0.00107	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	4.46e-05	0.00105	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	4.43e-05	0.00104	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.35e-05	0.00102	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—SDHA—dilated cardiomyopathy	4.31e-05	0.00101	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—ANKRD1—dilated cardiomyopathy	4.12e-05	0.000968	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.09e-05	0.000961	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	3.97e-05	0.000932	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—TAZ—dilated cardiomyopathy	3.88e-05	0.00091	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—AGT—dilated cardiomyopathy	3.8e-05	0.000891	CbGpPWpGaD
Losartan—ALB—Hemostasis—TTN—dilated cardiomyopathy	3.79e-05	0.000891	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ANKRD1—dilated cardiomyopathy	3.78e-05	0.000887	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.76e-05	0.000883	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.76e-05	0.000883	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	3.73e-05	0.000876	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—AGT—dilated cardiomyopathy	3.6e-05	0.000845	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	3.57e-05	0.000837	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—TAZ—dilated cardiomyopathy	3.55e-05	0.000834	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—SDHA—dilated cardiomyopathy	3.51e-05	0.000823	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.5e-05	0.000821	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.42e-05	0.000802	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.42e-05	0.000802	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	3.39e-05	0.000796	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	3.39e-05	0.000795	CbGpPWpGaD
Losartan—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	3.29e-05	0.000772	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	3.28e-05	0.000771	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—SDHA—dilated cardiomyopathy	3.21e-05	0.000754	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	3.2e-05	0.00075	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	3.2e-05	0.00075	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	3.19e-05	0.000749	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.17e-05	0.000745	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.07e-05	0.000722	CbGpPWpGaD
Losartan—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	3.06e-05	0.00072	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	3.04e-05	0.000714	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.97e-05	0.000697	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.92e-05	0.000685	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.88e-05	0.000676	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.84e-05	0.000667	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.8e-05	0.000657	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.8e-05	0.000657	CbGpPWpGaD
Losartan—ALB—Hemostasis—VCL—dilated cardiomyopathy	2.8e-05	0.000657	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.74e-05	0.000644	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.6e-05	0.000611	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.56e-05	0.000601	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	2.51e-05	0.000589	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	2.49e-05	0.000586	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.49e-05	0.000585	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	2.44e-05	0.000574	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	2.44e-05	0.000574	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	2.36e-05	0.000553	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	2.33e-05	0.000547	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	2.33e-05	0.000547	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	2.32e-05	0.000546	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	2.28e-05	0.000536	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.27e-05	0.000533	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	2.2e-05	0.000516	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	2.19e-05	0.000514	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	2.17e-05	0.00051	CbGpPWpGaD
Losartan—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	2.16e-05	0.000507	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	2.16e-05	0.000506	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	2.13e-05	0.000501	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.13e-05	0.0005	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	2.04e-05	0.000479	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.03e-05	0.000478	CbGpPWpGaD
Losartan—ALB—Metabolism—TAZ—dilated cardiomyopathy	2.03e-05	0.000477	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.02e-05	0.000474	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.02e-05	0.000474	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	1.98e-05	0.000465	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.96e-05	0.00046	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	1.94e-05	0.000455	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.93e-05	0.000454	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.91e-05	0.000448	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	1.89e-05	0.000444	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	1.89e-05	0.000444	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.88e-05	0.00044	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.85e-05	0.000434	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	1.85e-05	0.000434	CbGpPWpGaD
Losartan—ALB—Metabolism—SDHA—dilated cardiomyopathy	1.84e-05	0.000431	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	1.82e-05	0.000428	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.82e-05	0.000426	CbGpPWpGaD
Losartan—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	1.78e-05	0.000418	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	1.77e-05	0.000415	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.72e-05	0.000404	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.69e-05	0.000396	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	1.66e-05	0.00039	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	1.65e-05	0.000387	CbGpPWpGaD
Losartan—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	1.61e-05	0.000378	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	1.51e-05	0.000355	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	1.5e-05	0.000353	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.47e-05	0.000346	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	1.45e-05	0.000341	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.43e-05	0.000336	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	1.42e-05	0.000333	CbGpPWpGaD
Losartan—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	1.4e-05	0.00033	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—GPX1—dilated cardiomyopathy	1.38e-05	0.000324	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—CD36—dilated cardiomyopathy	1.34e-05	0.000315	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—GPX1—dilated cardiomyopathy	1.3e-05	0.000305	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	1.28e-05	0.000301	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.28e-05	0.000301	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—CD36—dilated cardiomyopathy	1.27e-05	0.000297	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.26e-05	0.000297	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.25e-05	0.000293	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—AGT—dilated cardiomyopathy	1.21e-05	0.000284	CbGpPWpGaD
Losartan—ALB—Hemostasis—CD36—dilated cardiomyopathy	1.2e-05	0.000281	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—GPX1—dilated cardiomyopathy	1.17e-05	0.000275	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	1.17e-05	0.000274	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.14e-05	0.000268	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—CD36—dilated cardiomyopathy	1.14e-05	0.000268	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—AGT—dilated cardiomyopathy	1.14e-05	0.000267	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.13e-05	0.000266	CbGpPWpGaD
Losartan—ALB—Hemostasis—RAC1—dilated cardiomyopathy	1.13e-05	0.000265	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.13e-05	0.000264	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.12e-05	0.000263	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.1e-05	0.000258	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1.1e-05	0.000257	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—AGT—dilated cardiomyopathy	1.09e-05	0.000256	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.09e-05	0.000256	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—AGT—dilated cardiomyopathy	1.03e-05	0.000241	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.01e-05	0.000236	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	9.91e-06	0.000233	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	9.88e-06	0.000232	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	9.82e-06	0.000231	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	9.81e-06	0.00023	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	9.79e-06	0.00023	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—GPX1—dilated cardiomyopathy	9.53e-06	0.000224	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	9.34e-06	0.000219	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—CD36—dilated cardiomyopathy	9.28e-06	0.000218	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.17e-06	0.000215	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.93e-06	0.00021	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.81e-06	0.000207	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.79e-06	0.000206	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—GPX1—dilated cardiomyopathy	8.73e-06	0.000205	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CD36—dilated cardiomyopathy	8.5e-06	0.0002	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—AGT—dilated cardiomyopathy	8.35e-06	0.000196	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.04e-06	0.000189	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.83e-06	0.000184	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—AGT—dilated cardiomyopathy	7.65e-06	0.00018	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.63e-06	0.000179	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—RAF1—dilated cardiomyopathy	7.58e-06	0.000178	CbGpPWpGaD
Losartan—ALB—Hemostasis—RAF1—dilated cardiomyopathy	7.49e-06	0.000176	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.87e-06	0.000161	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.48e-06	0.000152	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	5.79e-06	0.000136	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.68e-06	0.000133	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	5.64e-06	0.000132	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—EGFR—dilated cardiomyopathy	5.2e-06	0.000122	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	5.08e-06	0.000119	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	5.02e-06	0.000118	CbGpPWpGaD
Losartan—ALB—Metabolism—GPX1—dilated cardiomyopathy	4.99e-06	0.000117	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	4.88e-06	0.000115	CbGpPWpGaD
Losartan—ALB—Metabolism—CD36—dilated cardiomyopathy	4.86e-06	0.000114	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	4.48e-06	0.000105	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	4.4e-06	0.000103	CbGpPWpGaD
Losartan—ALB—Metabolism—AGT—dilated cardiomyopathy	4.37e-06	0.000103	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	4.37e-06	0.000103	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	4.36e-06	0.000102	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CD36—dilated cardiomyopathy	4.26e-06	9.99e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	4.08e-06	9.58e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	3.98e-06	9.33e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	3.93e-06	9.22e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AGT—dilated cardiomyopathy	3.83e-06	9e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	3.58e-06	8.4e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	3.49e-06	8.19e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	3.4e-06	7.98e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	3.06e-06	7.18e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.69e-06	6.32e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.62e-06	6.16e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.36e-06	5.54e-05	CbGpPWpGaD
